Prospective treatment of cerebrotendinous xanthomatosis with cholic acid therapy
- 27 December 2008
- journal article
- case report
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 31 (S2), 241-245
- https://doi.org/10.1007/s10545-008-0815-z
Abstract
Cerebrotendinous xanthomatosis (CTX) OMIM#213700 is a rare disorder of bile acid synthesis caused by deficiency of the enzyme sterol 27-hydroxylase. It results in deficiency of bile acids and accumulation of abnormal bile alcohols and accelerated cholesterol synthesis. CTX usually presents in the second or third decade with slowly progressive neurological dysfunction, cerebellar ataxia and premature atherosclerosis. Treatment with bile acid supplementation improves but does not completely reverse the neurological signs and symptoms. However, CTX is now known to be associated with a period of neonatal cholestasis. If it is diagnosed at this point, treatment may prevent the onset of neurological problems. We present the case histories and developmental findings in two affected siblings treated from infancy. We plan to continue regular neurodevelopmental reviews.Keywords
This publication has 20 references indexed in Scilit:
- Cerebrotendinous xanthomatosis: Need for early diagnosisIndian Journal of Dermatology, Venereology and Leprology, 2006
- Comparative effects of lovastatin and chenodeoxycholic acid on plasma cholestanol levels and abnormal bile acid metabolism in cerebrotendinous xanthomatosisMetabolism, 1994
- Bile acid biosynthesisBiochemistry, 1992
- Combined treatment with chenodeoxycholic acid and pravastatin improves plasma cholestanol levels associated with marked regression of tendon xanthomas in cerebrotendinous xanthomatosisMetabolism, 1991
- Bile acid therapies applied to patients suffering from cerebrotendinous xanthomatosisClinica Chimica Acta; International Journal of Clinical Chemistry, 1985
- Membrane effects of various drugs on isolated rat hepatocytes and erythrocytesToxicology and Applied Pharmacology, 1985
- Fast atom bombardment mass spectrometry in the diagnosis of cerebrotendinous xanthomatosisScandinavian Journal of Clinical and Laboratory Investigation, 1985
- Long-Term Treatment of Cerebrotendinous Xanthomatosis with Chenodeoxycholic AcidNew England Journal of Medicine, 1984
- A 25-hydroxylation pathway of cholic acid biosynthesis in man and rat.JCI Insight, 1976
- Chenodeoxycholic acid inhibits increased cholesterol and cholestanol synthesis in patients with cerebrotendinous XanthomatosisBiochemical Medicine, 1975